Lynne Fitzpatrick - 15 Sep 2026 Form 4 Insider Report for CME GROUP INC. (CME)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Sep 2026, 16:22:01 UTC
Prior SEC filing
17 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elizabeth Hensen, as Attorney-in-Fact for Lynne Fitzpatrick

Key filing fact

Lynne Fitzpatrick filed Form 4 for CME GROUP INC. (CME) on 17 Sep 2026.

Key facts

  • This page summarizes Lynne Fitzpatrick's Form 4 filing for CME GROUP INC. (CME).
  • 5 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Sep 2026, 16:22.

Change

  • Previous filing in this sequence was filed on 17 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001915955 Primary reporting owner

Fitzpatrick Lynne

Relationship
President and CFO
Address
20 SOUTH WACKER DRIVE, CHICAGO
Signature
/s/ Elizabeth Hensen, as Attorney-in-Fact for Lynne Fitzpatrick
Signature date
17 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CME transaction

Common Stock Class A

Award

Transaction value
Shares
+4,088
Change %
+17%
Price
$275.09*
Shares after
28,001
Date
15 Sep 2026
Ownership
Direct
Footnotes
F1
CME transaction

Common Stock Class A

Tax liability

Transaction value
Shares
-249
Change %
-0.89%
Price
$275.09*
Shares after
27,752
Date
15 Sep 2026
Ownership
Direct
Footnotes
F2
CME transaction

Common Stock Class A

Tax liability

Transaction value
Shares
-275
Change %
-0.99%
Price
$275.09*
Shares after
27,477
Date
15 Sep 2026
Ownership
Direct
Footnotes
F2
CME transaction

Common Stock Class A

Tax liability

Transaction value
Shares
-457
Change %
-1.7%
Price
$275.09*
Shares after
27,020
Date
15 Sep 2026
Ownership
Direct
Footnotes
F2
CME transaction

Common Stock Class A

Tax liability

Transaction value
Shares
-359
Change %
-1.3%
Price
$272.46*
Shares after
26,661
Date
16 Sep 2026
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.

Footnote F2

Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .